New study aims to unlock secrets of alcoholic liver disease

NCT ID NCT04106518

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is observing heavy drinkers with jaundice to learn more about alcoholic hepatitis, a serious liver condition. Researchers will track survival and liver function over 12 months, and collect genetic samples to better understand the disease. The goal is to improve diagnosis and knowledge, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could improve how doctors diagnose and predict outcomes for alcoholic hepatitis, and point toward new treatment targets.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly lead to a cure or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOLIC CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Association Hopital Saint Joseph - Marseille

    RECRUITING

    Marseille, France

  • Centre Hospitalier Universitaire

    RECRUITING

    Caen, France

  • Chr Angers

    RECRUITING

    Angers, France

  • Chru Besancon

    RECRUITING

    Besançon, France

  • Chu Montpellier

    RECRUITING

    Montpellier, France

  • Hopital Nord - Chu38 - La Tronche

    RECRUITING

    La Tronche, France

  • Hu Est Parisien Site St Antoine Aphp - Paris 12

    RECRUITING

    Paris, France

  • Hôpital Claude Huriez, CHU

    RECRUITING

    Lille, France

  • Hôpital Jean Verdier, AH-HP

    RECRUITING

    Bondy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.